|
|
Volumn 294, Issue 5540, 2001, Pages 87-89
|
|
Harnessing genomics and biotechnology to improve global health equity
a
a
NONE
(Canada)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GENES;
HEALTH;
GLOBAL HEALTH EQUITY;
BIOTECHNOLOGY;
HEPATITIS B VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MALARIA VACCINE;
MENINGITIS VACCINE;
BIOTECHNOLOGY;
DEVELOPING WORLD;
EQUITY;
HEALTH CARE;
AFRICA;
BIOTECHNOLOGY;
CANADA;
CUBA;
DEVELOPING COUNTRY;
FINANCIAL MANAGEMENT;
GENE TECHNOLOGY;
HEALTH CARE PLANNING;
INTERNATIONAL COOPERATION;
MEDICAL RESEARCH;
PLASMODIUM VIVAX;
PRIORITY JOURNAL;
SHORT SURVEY;
BIOTECHNOLOGY;
DEVELOPING COUNTRIES;
FINANCIAL SUPPORT;
FINANCING, GOVERNMENT;
GENOMICS;
HEALTH POLICY;
HUMANS;
PRIVATE SECTOR;
PUBLIC POLICY;
PUBLIC SECTOR;
WORLD HEALTH;
WORLD HEALTH ORGANIZATION;
HUMAN IMMUNODEFICIENCY VIRUS;
PLASMODIUM VIVAX;
|
|
EID: 0035812751
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1062633 Document Type: Short Survey |
|
Times cited : (113)
|
|
References (25)
|
